Mark C. Noe
15Patents
10h-index
14Co-inventors
65Inventor score
Filing activity: May 21, 1999 → Jul 29, 2008
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6919332B2 | N-substituted-heteroaryloxy-aryloxy-pyrimidine-2,4,6-trione metalloproteinase inhibitors | Chemistry; Metallurgy | 83 | Expired |
| US6235764A | Isothiazole derivatives useful as anticancer agents | Chemistry; Metallurgy | 77 | Expired |
| US6900201B2 | N-substituted-heteroaryloxy-aryl-spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors | Human Necessities | 50 | Expired |
| US6380214B1 | Heterocyclic derivatives useful as anticancer agents | Chemistry; Metallurgy | 33 | Expired |
| US7030242B2 | Selective inhibition of aggrecanase in osteoarthritis treatment | Chemistry; Metallurgy | 31 | Expired |
| US6841671B2 | Spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors | Chemistry; Metallurgy | 28 | Expired |
| US6916807B2 | Triaryl-oxy-aryl-spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors | Human Necessities | 28 | Expired |
| US6599890B1 | Arylsulfonyl hydroxamic acid derivatives | Chemistry; Metallurgy | 21 | Expired |
| US7790902B2 | Isothiazole derivatives useful as anticancer agents | Chemistry; Metallurgy | 13 | Active |
| US6548526B2 | Isothiazole derivatives useful as anticancer agents | Chemistry; Metallurgy | 10 | Expired |
| US6608104B2 | Gem substituted hydroxamic acids | Human Necessities | 9 | Expired |
| US6329397A | Hydroxy pipecolate hydroxamic acid derivatives | Chemistry; Metallurgy | 3 | Expired |
| US6706723B2 | Pyrimidine-2,4,6-trione metalloproteinase inhibitors | Chemistry; Metallurgy | 3 | Expired |
| US7462600B2 | Macrolides | Human Necessities | 1 | Expired |
| US7405218B2 | Isothiazole derivatives useful as anticancer agents | Chemistry; Metallurgy | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.